OpenResearchAlpha

bioRxiv · 18 Nov 2026

Combined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells

Benjamin Forgieh-index 1, Sarah Ferrier, Alicia A Goyeneche, Alexandra Bartolomucci, Desiree Marmo, Rewati Prakash, Abu SM Noman, Edith Zorychta, Lucy Gilbert, Julia V Burnier, Carlos M Telleriah-index 12

0
Citations
no database records one yet
0
Citations in 2026
so far
12
Leading author's h-index
Carlos M Telleria, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Platinum (Pt) based chemotherapy remains central to ovarian cancer (OC) treatment, but recurrent disease frequently develops Pt resistance and responds poorly to immune checkpoint inhibitors. Immunogenic cell death (ICD) links tumor cell killing to antitumor immunity; however, cisplatin (CDDP), widely used in OC, is an incomplete ICD inducer. We previously demonstrated that the HIV protease inhibitor nelfinavir (NFV) enhances CDDP induced OC cell death and promotes a lytic, pyroptosis associated phenotype. Here, we investigated whether NFV enhances the immunogenic consequences of CDDP treatment. RNA seq analysis of OC cells treated with CDDP, NFV, or their combination revealed enrichment of interferon (IFN) associated, cytoplasmic DNA sensing, inflammatory chemokine, and antigen presentation pathways following NFV containing treatments. NFV alone and CDDP plus NFV reduced mature Lamin A abundance and increased extranuclear double stranded DNA accumulation. Cytosolic fractionation and droplet digital PCR demonstrated increased cytosolic TP53 DNA, particularly following combined treatment. CDDP plus NFV increased STING and TBK1 phosphorylation, supporting engagement of the cGAS STING TBK1 signaling pathway. The combination enhanced release of inflammatory and ICD associated mediators, including HMGB1, IL18, and IFNbeta. Importantly, vaccination with CDDP plus NFV-treated murine ID8 OC cells protected immunocompetent female mice against subsequent live ID8 cell challenge, reducing tumor incidence and burden. In contrast, ID8 cells killed by freeze thaw-induced accidental necrosis provided no comparable protection. Collectively, these findings indicate that NFV enhances the immunogenic consequences of CDDP induced OC cell death, potentially involving cytoplasmic DNA accumulation and STING TBK1 signaling, and promotes protective antitumor immunity in vivo. These results support further investigation of NFV as a repurposed partner for Pt based chemotherapy and its potential combination with immunotherapy in OC.

Cancer biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Carlos M Telleria has the highest h-index among the authors (12).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (11)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.